Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · IEX Real-Time Price · USD
2.850
-0.050 (-1.72%)
At close: May 17, 2024, 4:00 PM
2.900
+0.050 (1.75%)
After-hours: May 17, 2024, 7:29 PM EDT
Akoya Biosciences Market Cap
Akoya Biosciences has a market cap or net worth of $141.74 million as of May 17, 2024. Its market cap has decreased by -40.87% in one year.
Market Cap
141.74M
Enterprise Value
164.65M
1-Year Change
-40.87%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since the IPO on April 16, 2021, Akoya Biosciences's market cap has decreased from $713.79M to $141.74M, a decrease of -80.14%. That is a compound annual growth rate of -40.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 17, 2024 | 140.80M | -1.68% |
| May 16, 2024 | 143.20M | 3.92% |
| May 15, 2024 | 137.80M | -3.77% |
| May 14, 2024 | 143.20M | -29.28% |
| May 13, 2024 | 202.50M | -3.39% |
| May 10, 2024 | 209.60M | -4.81% |
| May 9, 2024 | 220.20M | 9.01% |
| May 8, 2024 | 202.00M | 0.75% |
| May 7, 2024 | 200.50M | -0.99% |
| May 6, 2024 | 202.50M | 2.02% |
| May 3, 2024 | 198.50M | 1.22% |
| May 2, 2024 | 196.10M | 0.77% |
| May 1, 2024 | 194.60M | 3.68% |
| Apr 30, 2024 | 187.70M | -1.05% |
| Apr 29, 2024 | 189.70M | 1.61% |
| Apr 26, 2024 | 186.70M | -0.53% |
| Apr 25, 2024 | 187.70M | 0.27% |
| Apr 24, 2024 | 187.20M | - |
| Apr 23, 2024 | 187.20M | -2.30% |
| Apr 22, 2024 | 191.60M | 2.62% |
| Apr 19, 2024 | 186.70M | -1.32% |
| Apr 18, 2024 | 189.20M | -1.51% |
| Apr 17, 2024 | 192.10M | -1.79% |
| Apr 16, 2024 | 195.60M | -0.76% |
| Apr 15, 2024 | 197.10M | -2.91% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InfuSystem Holdings | 142.47M |
| American Well | 141.92M |
| I-Mab | 140.18M |
| Seer, Inc. | 138.96M |
| Corvus Pharmaceuticals | 138.86M |
| TruBridge | 134.32M |
| OptiNose | 133.95M |
| Karyopharm Therapeutics | 133.01M |